Universitetssykehuset Nord-Norge, Department of Neurology

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)	autosomal recessive limb-girdle muscular dystrophy type 2I	Active, not recruiting	Phase 3	2026-09-09		NCT05775848
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9	autosomal recessive limb-girdle muscular dystrophy type 2I	Active, not recruiting	Phase 3	2026-07-02		NCT07678775

Clinical trials